Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 25% ± 9% | |
retinal cone cell | 7 studies | 55% ± 13% | |
retinal rod cell | 7 studies | 44% ± 12% | |
retina horizontal cell | 5 studies | 44% ± 8% | |
cardiac muscle cell | 5 studies | 49% ± 12% | |
microglial cell | 5 studies | 26% ± 7% | |
mesothelial cell | 4 studies | 31% ± 11% | |
hepatocyte | 3 studies | 56% ± 21% | |
GABAergic neuron | 3 studies | 45% ± 7% | |
glutamatergic neuron | 3 studies | 50% ± 10% | |
oligodendrocyte | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3186.42 | 226 / 226 | 52% | 2.71 | 210 / 406 |
brain | 97% | 475.52 | 2566 / 2642 | 54% | 1.06 | 378 / 705 |
kidney | 99% | 352.72 | 88 / 89 | 49% | 1.82 | 443 / 901 |
adrenal gland | 99% | 3036.79 | 256 / 258 | 44% | 4.08 | 102 / 230 |
thymus | 99% | 491.75 | 649 / 653 | 31% | 0.70 | 190 / 605 |
esophagus | 93% | 344.83 | 1347 / 1445 | 34% | 0.76 | 63 / 183 |
uterus | 99% | 464.13 | 169 / 170 | 26% | 0.55 | 120 / 459 |
bladder | 100% | 354.57 | 21 / 21 | 13% | 0.31 | 67 / 504 |
lung | 89% | 272.55 | 513 / 578 | 23% | 0.48 | 263 / 1155 |
ovary | 88% | 212.21 | 159 / 180 | 17% | 0.29 | 74 / 430 |
intestine | 96% | 347.63 | 930 / 966 | 9% | 0.15 | 48 / 527 |
prostate | 96% | 343.48 | 235 / 245 | 4% | 0.08 | 22 / 502 |
heart | 99% | 3164.37 | 855 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 660.26 | 789 / 803 | 0% | 0 | 0 / 0 |
pancreas | 36% | 74.86 | 118 / 328 | 57% | 1.70 | 102 / 178 |
breast | 74% | 140.70 | 340 / 459 | 12% | 0.24 | 137 / 1118 |
spleen | 85% | 181.06 | 205 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 83% | 194.31 | 1103 / 1335 | 0% | 0 | 0 / 0 |
adipose | 80% | 356.44 | 968 / 1204 | 0% | 0 | 0 / 0 |
skin | 66% | 128.43 | 1191 / 1809 | 8% | 0.15 | 40 / 472 |
stomach | 49% | 113.43 | 175 / 359 | 4% | 0.06 | 11 / 286 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.10 | 3 / 45 |
peripheral blood | 3% | 5.59 | 32 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.06 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000377 | Biological process | regulation of reactive oxygen species metabolic process |
GO_0016121 | Biological process | carotene catabolic process |
GO_0016124 | Biological process | xanthophyll catabolic process |
GO_1901826 | Biological process | zeaxanthin catabolic process |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0051881 | Biological process | regulation of mitochondrial membrane potential |
GO_0062172 | Biological process | lutein catabolic process |
GO_0042574 | Biological process | retinal metabolic process |
GO_0016116 | Biological process | carotenoid metabolic process |
GO_1901176 | Biological process | lycopene catabolic process |
GO_0016119 | Biological process | carotene metabolic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0003834 | Molecular function | beta-carotene 15,15'-dioxygenase activity |
GO_0102076 | Molecular function | beta,beta-carotene-9',10'-cleaving oxygenase activity |
GO_0010437 | Molecular function | 9,10 (9', 10')-carotenoid-cleaving dioxygenase activity |
GO_0010436 | Molecular function | carotenoid dioxygenase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0016702 | Molecular function | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
Gene name | BCO2 |
Protein name | Beta-carotene oxygenase 2 Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (B-diox-II) (Beta,beta-carotene 9',10'-oxygenase) (Beta-carotene dioxygenase 2) Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.71) |
Synonyms | BCDO2 |
Description | FUNCTION: Broad specificity mitochondrial dioxygenase that mediates the asymmetric oxidative cleavage of carotenoids. Cleaves carotenes (pure hydrocarbon carotenoids) such as all-trans-beta-carotene and lycopene as well as xanthophylls (oxygenated carotenoids) such as zeaxanthin, lutein and beta-cryptoxanthin at both the 9,10 and the 9',10' carbon-carbon double bond. Through its function in carotenoids metabolism regulates oxidative stress and the production of important signaling molecules. . |
Accessions | ENST00000531169.5 [Q9BYV7-2] E9PS89 H0YCN8 ENST00000361053.8 [Q9BYV7-5] V9GYA9 ENST00000532593.5 [Q9BYV7-6] ENST00000357685.11 [Q9BYV7-1] ENST00000526088.5 [Q9BYV7-4] ENST00000438022.5 [Q9BYV7-2] H0YCL7 E9PPP9 Q9BYV7 ENST00000530677.1 ENST00000527939.1 ENST00000531003.1 ENST00000525175.1 ENST00000532612.5 ENST00000534550.5 |